IDYA
IDEAYA Biosciences, Inc.
Key Financials
Operating Income
$-159313000
↑ 51.3%
Revenue
$218.7M
↑ 3024.4%
Net Income
$-113698000
↑ 58.6%
EPS (Diluted)
$-1.28
↑ 61.9%
Total Liabilities
$86.4M
↑ 33.0%
Total Assets
$1.1B
↓ 1.3%
Shareholders' Equity
$1.0B
↓ 3.4%
Cash & Equivalents
$112.8M
↑ 33.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IDYA |
| Company Name | IDEAYA Biosciences, Inc. |
| CIK | 1676725 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-443-6209 |